At this stage, the Company is unable to provide any meaningfulguidance as to the potential financial impact arising from this agreement given the software as aservice (SAS) usage-based model for monthly license fees.
At some point they are going to have to sell access to this product for actual currency and put something in the "Receipts from customers" cash flow line.
Every time they sell access, exclusivity or trial, no money changes hands.
Ann: EIQ Licenses Software to Respiri - Remote Patient Monitoring, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $154.8M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.0¢ | 23.0¢ | $140.4K | 600.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 224532 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 70915 | 3 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |